Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Presepsin and Syndecan-1 as Biomarkers for Early Diagnosis and Prognosis of Sepsis Following Major Surgeries

NCT04718623 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT04718623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04718623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Presepsin and Syndecan-1 as Biomarkers for Early Diagnosis and Prognosis of Sepsis Following Major Surgeries
Lead sponsor
Alexandria University
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2021
Completion date
April 30, 2022
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diagnoses, syndromes, and conditions, sepsis following a procedure